AMD 070,
AMD 11070,
AMD-070,
AMD-11070,
AMD070,
AMD11070,
N'-((1H-benzo(d)imidazol-2-yl)methyl)-N'-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine,
558447-26-0,
AMD-070,
(S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine,
Mavorixafor,
AMD070,
AMD 070,
AMD11070,
UNII-0G9LGB5O2W,
AMD-11070,
0G9LGB5O2W,
CHEMBL518924,
X4P-001,
C21H27N5,
N'-(1H-benzimidazol-2-ylmethyl)-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine,
AMD 11070,
Mavorixafor [USAN],
compound 2 [PMID: 20297846],
AMD-070; Mavorixafor,
GTPL8580,
SCHEMBL2511950,
CTK8C0587,
QCR-228,
CHEBI:138865,
X4P-001-IO,
X4P-001-LD,
BCP07108,
EX-A2661,
8157AB,
ANW-64931,
BDBM50315305,
MFCD11977316,
WHO 10724,
ZINC33359232,
AMD-070 HCl 75%(w/w%),
CS-0352,
CS-1257,
DB05501,
SB19804,
NCGC00378947-02,
AJ-85915,
AK103290,
HY-50101,
AX8234829,
TC-153676,
ST24036370,
C20266,
W-5505,
(S)-N-((1H-benzo[d]imidazol-2-yl)methyl)-N-(4-aminobutyl)-5,6,7,8-tetrahydroquinolin-8-amine,
558441-90-0,
N'-((1H-benzo(d)imidazol-2-yl)methyl)-N'-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine,
N-(1H-benzimidazol-2-ylmethyl)-N-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine,
D0O2XQ,
RW3962,
CID11256587,
A11315,
S14-0353,
N-(1H-benzoimidazol-2-ylmethyl)-N-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine,
N'-(1H-BENZIMIDAZOL-2-YLMETHYL)-N'-((S)-5,6,7,8-TETRAHYDROQUINOLIN-8-YL)BUTANE-1,4-DIAMINE,
N'-(1H-Benzo[d]imidazol-2-ylmethyl)-N'-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine Trihydrobromide Dihydrate,